Saliva and plasma levels of cardiac-related biomarkers in post-myocardial infarction patients

scientific article published on 28 April 2017

Saliva and plasma levels of cardiac-related biomarkers in post-myocardial infarction patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JCPE.12740
P8608Fatcat IDrelease_zuc2ahy4qzardln57ugngqx37u
P698PubMed publication ID28453865

P50authorAnna NorhammarQ61089825
Nilminie RathnayakeQ96139382
P2093author name stringTimo Sorsa
Taina Tervahartiala
Lars Rydén
Anders Gustafsson
Barbro Kjellström
Kåre Buhlin
Christian Löwbeer
Bjorn Klinge
PAROKRANK Steering Committee
P2860cites workSalivary biomarkers: toward future clinical and diagnostic utilitiesQ26851200
Can Saliva Proteins Be Used to Predict the Onset of Acute Myocardial Infarction among High-Risk Patients?Q28080787
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizationQ28283679
Effect of periodontal treatment on the protein composition of whole and parotid salivaQ28284959
Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health SurveyQ33882323
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarctionQ33917874
Utility of salivary biomarkers for demonstrating acute myocardial infarction.Q33936565
Universal definition of myocardial infarctionQ34007701
Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trialsQ34614873
Salivary biomarkers for detection of systemic diseasesQ34700220
The diagnostic applications of saliva--a reviewQ34720733
Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease)Q35680166
Inflammation and cardiac outcomeQ35835539
Gingival crevicular fluid and serum cystatin c levels in periodontal health and diseaseQ37304861
Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).Q38179689
Cystatin C: a kidney function biomarkerQ38413763
Oral infections and cardiovascular diseaseQ38429185
Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseasesQ38667969
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndromeQ43715189
Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non-smokersQ43784908
Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility studyQ44204171
N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromesQ44446907
Salivary cystatin activity and cystatin C in experimental gingivitis in non-smokersQ44718374
The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarctionQ45011958
Validation of a high-sensitivity assay for C-reactive protein in human saliva.Q51891330
Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction.Q54580805
Unstimulated whole saliva creatine phosphokinase in acute myocardial infarction.Q54585675
Third Universal Definition of Myocardial InfarctionQ56535247
Third Universal Definition of Myocardial InfarctionQ56627595
Protein composition of whole and parotid saliva in healthy and periodontitis subjectsQ56700909
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectbiomarkerQ864574
P304page(s)692-699
P577publication date2017-04-28
P1433published inJournal of Clinical PeriodontologyQ15638559
P1476titleSaliva and plasma levels of cardiac-related biomarkers in post-myocardial infarction patients
P478volume44

Reverse relations

Q51243763Salivary levels of phosphorus and urea as indices of their plasma levels in nephropathic patients.cites workP2860

Search more.